CEO Ádám Balog sheds light on outstanding figures.
Hungarian subsidiary also posts profit.
What will the bank spend it on?
Challanges all over the place.
Anaemic performance seen in early 2017.
Operating profit margin also seen higher.
Leading pharma reports robust Q1 results.
New strategy works.
The plan is to pay dividend already for 2017.
Here are OTP's expectations for 2017.
Just like Sergey Bubka.
Only Upstream EBITDA did not disappoint.
INA turns huge net loss into profit.
2016 was a special year.
Risks all over the place.
Board of Directors proposal to AGM.
Earnings report scheduled for next week.
Profit doubled, yet share price is falling.
Analysts expect major profit growth for Q416.